Article History
First Online: 26 November 2018
Competing interests
: A.R.M. is receiving research support from AbbVie and Takeda under the framework of the Christian Doppler Research Society. He has received further consultation fees and/or speaker honoraria from AbbVie, Merck Sharp & Dohme, Takeda, Janssen-Cilag, Amgen, Sandoz and Pfizer. H.T. has received speaker honoraria from AbbVie, Janssen-Cilag, Merck Sharp & Dohme and Takeda. T.R. receives an unrestricted research grant from AbbVie, further consultation fees and/or honoraria from Abbvie, Astellas, Dr Falk, Gilead, GSK, Hospira, Janssen, MSD, Novartis, Pfizer, Sandoz and Takeda.